Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SENSORION | 57,082,287 | net | 28 Jan 2026 | tx 5+57,082,287 |
| GENSIGHT BIOLOGICS S.A. | 29,495,428 | net | 03 Jul 2025 | tx 9+29,495,428 |
| CinCor Pharma, Inc. | 4,220,979 | reported | 15 Aug 2022 | tx 1+133,333 |
| BioAmber Inc. | 3,802,780 | reported | 14 May 2013 | tx 2+1,760,000 |
| HOOKIPA Pharma Inc. | 3,177,574 | reported | 21 Apr 2021 | tx 8−654,837 |
| ABIVAX | 2,904,977 | net | 12 Jan 2026 | tx 11+5,050,866−2,145,889 |
| PIXIUM VISION | 2,489,260 | net | 08 Jan 2024 | tx 2+2,600,000−110,740 |
| Flexion Therapeutics Inc | 2,095,491 | reported | 29 Oct 2014 | tx 6+2,105,491−15,251,494 |
| INVENTIVA | 1,708,738 | net | 29 Sept 2021 | tx 2+1,708,738 |
| Omthera Pharmaceuticals, Inc. | 0 | reported | 18 Jul 2013 | tx 12+7,948,982−15,965,043 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Jan 2026 | PURCHASE | SENSORION | 10,714,285 | 0.28 EUR | |
| 12 Jan 2026 | SALE | ABIVAX | 950,000 | — | |
| 28 Oct 2025 | SALE | ABIVAX | 590,877 | 94.16 EUR | |
| 28 Oct 2025 | SALE | ABIVAX | 590,877 | — | |
| 03 Jul 2025 | PURCHASE | GENSIGHT BIOLOGICS S.A. | 5,882,353 | 0.17 EUR | |
| 12 Mar 2025 | PURCHASE | GENSIGHT BIOLOGICS S.A. | 889,680 | 0.22 EUR | |
| 31 Dec 2024 | PURCHASE | GENSIGHT BIOLOGICS S.A. | 2,663,353 | 0.28 EUR | |
| 06 Nov 2024 | PURCHASE | GENSIGHT BIOLOGICS S.A. | 2,812,223 | 0.35 EUR | |
| 09 May 2024 | PURCHASE | GENSIGHT BIOLOGICS S.A. | 5,063,291 | 0.40 EUR | |
| 11 Apr 2024 | PURCHASE | SENSORION | 1,587,301 | 0.63 EUR | |
| 08 Feb 2024 | PURCHASE | SENSORION | 12,280,701 | 0.57 EUR | |
| 07 Feb 2024 | PURCHASE | GENSIGHT BIOLOGICS S.A. | 5,224,660 | 0.38 EUR | |
| 08 Jan 2024 | SALE | PIXIUM VISION | 110,740 | 0.63 EUR | |
| 21 Nov 2023 | CONVERSION | GENSIGHT BIOLOGICS S.A. | 3,038,279 | 0.71 EUR | |
| 20 Oct 2023 | PURCHASE | ABIVAX | 1,200,000 | 11.60 EUR | |
| 20 Oct 2023 | PURCHASE | ABIVAX | 1,200,000 | — | |
| 04 Aug 2023 | PURCHASE | GENSIGHT BIOLOGICS S.A. | 21 | 100000.00 EUR | |
| 03 Aug 2023 | PURCHASE | SENSORION | 25,000,000 | 0.28 EUR | |
| 27 Feb 2023 | PURCHASE | ABIVAX | 1,535,000 | 6.50 EUR | |
| 07 Sept 2022 | PURCHASE | ABIVAX | 1 | 309520.00 EUR | |
| 02 Sept 2022 | PURCHASE | ABIVAX | 584,000 | 8.36 EUR | |
| 15 Aug 2022 | PURCHASE | CinCor Pharma, Inc. | 133,333 | 30.00 USD | |
| 29 Sept 2021 | PURCHASE | INVENTIVA | 138,880 | — | |
| 27 Jul 2021 | PURCHASE | ABIVAX | 261,865 | 30.55 EUR | first after silence |
| 11 Jun 2019 | PURCHASE | SENSORION | 7,500,000 | 1.00 EUR | first after silence |
4 purchases reported after at least 12 months of silence — most recent on 27 Jul 2021.